Clinical Trial Update: Parenteral Ascorbic Acid Repletion in TransplantatIon [Phase 4]

View source ↗

Summary

The Phase 4 trial evaluating parenteral ascorbic acid repletion in liver transplantation has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant Failure
• Liver Transplant Rejection

Drugs mentioned

• Parenteral ascorbic acid (ascorbic acid)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Liver Transplant Failure and Rejection | Phase 4 | Status: SUSPENDED